ARCHIVES

Two New Therapies For Metastatic Cancer Highlighted At AACR Annual Meeting

This article is from The Cancer Letter archive.

Vol. 26 No. 8 | August 29, 2003

Download PDF Visit The Full Archive

Related Articles

Tyrosine Kinase Inhibitor Encoraging For NSCLC

July 27, 2001

MD Anderson Survey Shows Faculty Dissatisfaction with Top Leaders

May 23, 2014

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

July 28, 2006

Funding Opportunities: Lymphoma Foundation Offers Two-Year Fellowship Grants

July 31, 1998

In Brief: Cooperative Group Investigators Treat 10 For Every Patient In Protocols – Holland

October 31, 1975

CDC Contribution To National Dialogue Raises Questions About Ties With ACS.

September 22, 2000